---
content_type: page
description: 'This section provides the list of required and recommended readings
  for each session of the course. '
draft: false
learning_resource_types:
- Readings
ocw_type: CourseSection
title: Readings
uid: 2947c805-f872-6255-a8f2-ca8b8a286944
---
{{< tableopen >}}{{< theadopen >}}{{< tropen >}}{{< thopen >}}
SES #
{{< thclose >}}{{< thopen >}}
TOPICS
{{< thclose >}}{{< thopen >}}
READINGS
{{< thclose >}}{{< trclose >}}{{< theadclose >}}{{< tbodyopen >}}{{< tropen >}}{{< tdopen >}}
1
{{< tdclose >}}{{< tdopen >}}
Introduction From Discovery to Market: An Integrated View
{{< tdclose >}}{{< tdopen >}}

### Required

Jack, Andrew. "{{% resource_link "1b90f8c6-b05d-40fb-ac6c-018dfabfb4f8" "Pharmaceuticals: Back to the Lab" %}}," *Financial Times*, August 10, 2013.

Munos, B. "{{% resource_link "7b6fdaa7-e1c0-4b78-a8ce-92948ec9dc45" "Lessons from 60 Years of Pharmaceutical Innovation" %}}." *Nature Reviews Drug Discovery* 8 (2009): 959–68.

U.S. Food and Drug Administration. {{% resource_link "a8251b3d-0ba1-45eb-ab97-6c6424175eee" "\"FY 2011 Innovative Drug Approvals.\" (PDF - 5.0MB)" %}} U.S. Department of Health and Human Services, U.S. Food and Drug Administration.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
2
{{< tdclose >}}{{< tdopen >}}
Brief Economic History of the Pharmaceutical Industry
{{< tdclose >}}{{< tdopen >}}

### Required

Rang, H. P., ed. Chapters 1–3 in *Drug Discovery and Development: Technology in Transition*. Churchill Livingstone, 2006, pp. 3–40. ISBN: 9780443064203.

Saftlas, Herman. "Healthcare: Pharmaceuticals." *Standard & Poor's Industry Surveys*. June 4, 2009. *S&P Net Advantage*.

U.S. Food and Drug Administration. ["FY 2011 Innovative Drug Approvals." (PDF - 5.0MB)](https://www.biopreneur.org/images/FY%202011%20Innovative%20Drug%20Approvals.pdf) U.S. Department of Health and Human Services, U.S. Food and Drug Administration.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
3
{{< tdclose >}}{{< tdopen >}}
The Pharmaceutical Industry and the Drug Development Process; Basic Science
{{< tdclose >}}{{< tdopen >}}
No Readings
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
4
{{< tdclose >}}{{< tdopen >}}
Business of Biopharmaceuticals
{{< tdclose >}}{{< tdopen >}}

### Required

Silver, Steven. "Healthcare: Pharmaceuticals." *Standard & Poor's Industry Surveys*. August 13, 2009. *S&P Net Advantage*.

Lawrence, Stacy. "{{% resource_link "1012dfc3-8241-416e-b2fb-baca5700605e" "Looking for an Oasis" %}}." *BioCentury, The Bernstein Report on Biobusiness* 16, no. 3 (2008): A1–A10.

Johnson, Avery. "{{% resource_link "0bdf0f1e-93aa-40c5-b4fc-4f5d15ad7370" "As Drug Industry Struggles, Chemists Face Layoff Wave" %}}," *Wall Street Journal*, December 11, 2007.

Martinez, Barbara. "{{% resource_link "6d99df8f-827f-46d1-9976-ad0151c171a4" "Big Pharma Faces Grim Prognosis: Industry Fails to Find New Drugs to Replace Wonders Like Lipitor" %}}," *Wall Street Journal*, December 6, 2007.

Silberman, Steve. "{{% resource_link "21729e0e-49fc-4007-a026-6d8d4dc385b1" "Placebos are Getting More Effective. Drugmakers are Desperate to Know Why" %}}." *Wired Magazine* 17.09, August 2009.

### Recommended

{{% resource_link "4095f494-c825-48dd-a6ca-155d5e3018e7" "Merck & Schering-Plough Merger Investor Presentation (PDF)" %}} March 9, 2009. Merck Schering-Plough.

Schoeberl, B., E. A. Pace, et al. "{{% resource_link "92734b0a-98a8-493e-bc47-0deadf0cda3d" "Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis" %}}." *Science Signaling* 77, no. 2 (2009): ra31.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
5
{{< tdclose >}}{{< tdopen >}}
Accelerating Cancer Cures: A Global Frontier
{{< tdclose >}}{{< tdopen >}}
Skloot, Rebecca. "{{% resource_link "555597cc-d117-4685-9bd6-bebf8c563248" "*About The Immortal Life of Henrietta Lacks*" %}}."
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
6
{{< tdclose >}}{{< tdopen >}}
Clinical Drug Development
{{< tdclose >}}{{< tdopen >}}
Burton, Thomas M. "{{% resource_link "4881ce81-bee5-4e1a-ac19-1ec8d653fac6" "By Learning from Failures, Lilly Keeps Drug Pipeline Full" %}}," *Wall Street Journal*, April 21, 2004.
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
7
{{< tdclose >}}{{< tdopen >}}
Drug Delivery Systems
{{< tdclose >}}{{< tdopen >}}

### Recommended

Alves, S., E. Régulier, et al. "{{% resource_link "6aa51b20-afdc-48e6-a912-9f6a06e06989" "Striatal and Nigral Pathology in a Lentiviral Rat Model of Machado-Joseph Disease" %}}." *Human Molecular Genetics* 17, no. 14 (2008): 2071–83.

Moreira, J. N., A. Santos, et al. "{{% resource_link "e1edb22c-5cc6-450d-9cdd-0c81f95b4124" "Non-Viral Lipid-Based Nanoparticles for Targeted Cancer Systemic Gene Silencing" %}}." *Journal of Nanoscience and Nanotechnology* 8, no. 18 (2008): 2187–204.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
8–10
{{< tdclose >}}{{< tdopen >}}

Regulation

Emerging Pharmaceutical Science and Technology I

Manufacturing I

Reimbursement

Emerging Pharmaceutical Science and Technology II

{{< tdclose >}}{{< tdopen >}}

### Required

Rubin, L. "{{% resource_link "61ba45e4-69d8-4ca7-b1a5-5e73e816b318" "Stem Cells and Drug Discovery: The Beginning of a New Era?" %}}" *Cell* 132 (2008): 549–52.

### Recommended

Radley, D. C., S. N. Finkelstein, et al. "{{% resource_link "fea4caca-880b-4f75-ace0-f46660734142" "Off-label Prescribing Among Office-based Physicians" %}}." *Archives of Internal Medicine* 166 no. 9 (2006): 1021–26.

Rubin, L., and F. J. de Sauvage. "{{% resource_link "6be8f22c-341f-47d0-aedb-5944780ca4a8" "Targeting the Hedgehog Pathway in Cancer" %}}." *Nature Reviews Drug Discovery* 5, no. 12 (2006): 1026–33.

{{% resource_link "c1848765-0b76-4a3d-a11a-e33cce9e9790" "*The Burrill Report*" %}} 3, no. 9 (2013).

Jones, Matt. "GenomeWeb Feature: Slow, Steady Decline in NIH Funding Leads Researchers to Fear Future Cuts," *GenomeWeb Daily News*, July 18, 2013.

Philippidis, Alex. "{{% resource_link "e92e9a9f-525d-4b7b-bc59-54c8c9aa23b9" "Researchers Chafe as NIH Budgets Shrivel" %}}," *Genetic Engineering & Biotechnology News*, September 13, 2013.

"{{% resource_link "de51c861-603a-4efe-9431-81128049be3e" "As VC Falters, Early-stage Biotechs Look Elsewhere for Cash" %}}," *FierceBiotech*, October 21, 2013.

"Universities Stepping Up Efforts To Discover Drugs," *Forbes*, October 21, 2013.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
11–13
{{< tdclose >}}{{< tdopen >}}

Manufacturing II

Manufacturing III

Student Presentations

{{< tdclose >}}{{< tdopen >}}

### Required

Thayer, A. M. "{{% resource_link "d3488ed4-9f68-4fbd-b35e-ed9f33c2b0cc" "The New Copycats" %}}." *Chemical & Engineering News* 91, no. 40 (2013): 15–23.

Wechsler, J. "{{% resource_link "e79c787b-5745-4773-83b4-7a2279d46671" "Drug Quality at Center Stage for FDA and Manufacturers" %}}." *BioPharm International* 26, no. 1 (2013): 10–12.

Kozlowski, S., J. Woodcock, et al. "{{% resource_link "50cba726-1d58-4c61-ad40-f05c8be89bee" "Developing the Nation's Biosimilars Program" %}}." *The New England Journal of Medicine* 365, no. 5 (2011): 385–88.

Thomas, Katie. "{{% resource_link "b091d331-2f66-4790-9163-6dc6942693e6" "Lapses at Big Drug Factories Add to Shortages and Danger" %}}," *New York Times*, October 17, 2012.

Basu, P., G. Joglekar, et al. "{{% resource_link "c3e2b46c-2e43-4d09-88a2-cf0c7a80ac85" "Analysis of Manufacturing Costs in Pharmaceutical Companies" %}}." *Journal of Pharmaceutical Innovation* 3, no. 1 (2008): 30–40.

{{% resource_link "d4794685-b2d8-4bfd-afd7-082b36b49fec" "\"Quality Manufacturing: A Blockbuster Opportunity for Pharmaceuticals, An Economist Intelligence Unit White Paper Written in Co-operation with Oracle.\" (PDF)" %}} *Economist Intelligence Unit, The Economist*, September 2005.

"{{% resource_link "b72fe1f2-f27e-4129-91d4-2e74836fb419" "Business: Trouble in the Making; Pharmaceuticals" %}}." *The Economist* 364, no. 8288 (2002).

### Recommended

{{% resource_link "0cc62e6a-42f0-45a0-aa14-05861db891be" "\"Guidance for Industry Q8(R2) Pharmaceutical Development.\" (PDF)" %}} ICH Revision 2. U.S. Department of Health and Human Services, Food and Drug Administration, November 2009.

{{% resource_link "23e05c3b-8aa3-418c-a4fd-332d26f7cd99" "\"Guidance for Industry Q10 Pharmaceutical Quality System.\" (PDF)" %}} ICH. U.S. Department of Health and Human Services, Food and Drug Administration, April 2009.

{{< tdclose >}}{{< trclose >}}{{< tbodyclose >}}{{< tableclose >}}